Search
for
Sort by
Research 61–90 of 154
- Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
- Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review
- New insights into the phenomenon of remissions and relapses in autoimmune diseases and the puzzle of benign autoantibodies in healthy individuals
- Biomedical applications of organoids in genetic diseases
- Treg–tissue cell interactions in repair and regeneration
- Biomedical engineering approaches for the delivery of JAGGED1 as a potential tissue regenerative therapy
- Cellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective
- Organoid‐Guided Precision Medicine: From Bench to Bedside
- Preponderance of serum and intra-hepatic 5α-dihydrotestosterone in males with hepatocellular carcinoma despite low circulating androgen levels
- Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
- Thrombophilia and Polycythemia in a Woman With Budd-Chiari Syndrome
- Prospect of Stem Cell Conditioned Medium in Regenerative Medicine
- Global Adiposity Rather Than Abnormal Regional Fat Distribution Characterizes Women with Polycystic Ovary Syndrome
- Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS)
- Repurposing of approved cardiovascular drugs
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Generation and characterization of rat liver stem cell lines and their engraftment in a rat model of liver failure
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Prevalence of hepatic steatosis in women with polycystic ovary syndrome
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Medical Treatment of Hepatocellular Carcinoma: Any Progress?
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
- Prevention of Alopecia in Medical and Interventional Chemotherapy Patients
- The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men